Monthly Archives: November 2013

Revival of an old malaria vaccine strategy

sporozoites in a mosquito salivary gland

The recent Parasites and Vectors blog by Vera Unwin picked up on the attention given by the media to the encouraging announcements concerning the RTS,S malaria vaccine. This vaccine, as others have done, deploys the strategy of attacking the sporozoite stages of the parasite as they enter the body following the bite of an infected… Read more »


The RTS,S vaccine: a tool for malaria control


The latest results from the RTS,S Phase III trials have fuelled considerable excitement from the media, with talk of the “World’s first malaria vaccine” and its potential to “save 200,000 lives  a year”. RTS,S was developed in partnership by Glaxo Smith Klein (GSK) and the PATH Malaria Vaccine Initiative (MVI), and has been trialled across thirteen… Read more »